Division of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
MAXIMUS Federal, contracting agency to the Division of Viral Diseases, Centers for Disease Control and Prevention Atlanta, Georgia.
Clin Infect Dis. 2018 May 2;66(10):1528-1534. doi: 10.1093/cid/cix1034.
In 2014, a nationwide outbreak of severe respiratory illness occurred in the United States, primarily associated with enterovirus D68 (EV-D68). A proportion of illness was associated with rhinoviruses (RVs) and other enteroviruses (EVs), which we aimed to characterize further.
Respiratory specimens from pediatric and adult patients with respiratory illness were submitted to the Centers for Disease Control and Prevention during August 2014-November 2014. While initial laboratory testing focused on identification of EV-D68, the negative specimens were typed by molecular sequencing to identify additional EV and RV types. Testing for other pathogens was not conducted. We compared available clinical and epidemiologic characteristics among patients with EV-D68 and RV species A-C identified.
Among 2629 typed specimens, 1012 were EV-D68 (39%) and 81 (3.1%) represented 24 other EV types; 968 were RVs (37%) covering 114 types and grouped into 3 human RV species (RV-A, 446; RV-B, 133; RV-C, 389); and 568 (22%) had no RV or EV detected. EV-D68 was more frequently identified in patients who presented earlier in the investigation period. Among patients with EV-D68, RV-A, RV-B, or RV-C, the age distributions markedly differed. Clinical syndromes and intensive care unit admissions by age were largely similar.
RVs were commonly associated with severe respiratory illness during a nationwide outbreak of EV-D68, and most clinical. Characteristics were similar between groups. A better understanding of the epidemiology of RVs and EVs is needed to help inform development and use of diagnostic tests, therapeutics, and preventive measures.
2014 年,美国发生了一起全国范围的严重呼吸道疾病疫情,主要与肠道病毒 D68(EV-D68)有关。一部分病例与鼻病毒(RV)和其他肠道病毒(EV)有关,我们旨在进一步对其进行特征描述。
2014 年 8 月至 11 月,向美国疾病控制与预防中心(Centers for Disease Control and Prevention)提交了儿科和成年呼吸道疾病患者的呼吸道标本。虽然最初的实验室检测主要集中在鉴定 EV-D68,但对阴性标本进行了分子测序以鉴定其他 EV 和 RV 型别。未进行其他病原体的检测。我们比较了鉴定出的 EV-D68 患者和 RV 种 A-C 患者的临床和流行病学特征。
在 2629 个分型标本中,1012 个为 EV-D68(39%),81 个(3.1%)代表 24 种其他 EV 型别;968 个为 RV(37%),涵盖 114 种型别,并分为 3 种人类 RV 种(RV-A,446;RV-B,133;RV-C,389);568 个(22%)标本中未检测到 RV 或 EV。EV-D68 在调查期间较早就诊的患者中更为常见。在 EV-D68 患者中,RV-A、RV-B 或 RV-C 的年龄分布明显不同。按年龄分组的临床综合征和重症监护病房入院率基本相似。
在 EV-D68 全国性疫情中,RV 通常与严重呼吸道疾病相关,且大多数临床特征相似。了解 RV 和 EV 的流行病学情况有助于指导诊断检测、治疗和预防措施的开发和使用。